| Supplier |
Ace Therapeutics |
| Product # |
NSC1088 |
| Pricing |
Inquiry
|
| Product Size |
50 µg
|
| Purity |
> 75 % as determined by SDS-PAGE
|
| Product Type |
Proteins
|
| Endotoxin |
< 1.0 EU per μg of the protein as determined by the LAL method
|
| Activity |
Measured in a cell proliferation assay using BALB/c 3T3 mouse fibroblasts. The ED50 for this effect is typically 5-30 ng/mL.
|
| Protein Construction |
A DNA sequence encoding the canine FGF9 (NP_002001.1) (Leu4-Ser208) was expressed with the Fc region of mouse IgG1 at the N-terminus.
|
| Accession# |
NP_002001.1
|
| Expressed Host |
HEK293 Cells
|
| Species |
Canine
|
| Predicted N Terminal |
Asp
|
| Molecule Mass |
The recombinant canine FGF9 comprises 441 amino acids and has a predicted molecular mass of 49.8 kDa. The apparent molecular mass of the protein is approximately 50 kDa in SDS-PAGE under reducing conditions.
|
| Formulation |
Lyophilized from sterile PBS, pH 7.4.Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
|
| Shipping |
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
|
| Stability & Storage |
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
| Reconstitution |
A hardcopy of datasheet with reconstitution instructions is sent along with the products. Please refer to it for detailed information.
|